Treatment Strategies for Atopic Dermatitis in Adults Who Exhibit Non-Allergic Comorbidities꞉ Real-Life Data from a Tertiary Greek Hospital
Keywords:
Atopic dermatitis, comorbidities, treatment, real lifeReferences
Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017; 35(3):283–289. DOI: 10.1016/j.det.2017.02.002. PMID: 28577797
Thyssen JP, Halling A, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis—what does the evidence say? J Allergy Clin Immunol. 2023;151(5): 1155-1162. DOI: 10.1016/j.jaci.2022.12.002. PMID: 36621338
Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-1431. DOI: 10.1111/jdv.18345. PMID: 35980214
Silverberg, J. I., Gelfand, J. M., Margolis, D. J., et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Ann Allergy Asthma Immunol 2018 Nov;121(5): 604612.e3. DOI: 10.1016/j.anai.2018.07.042. PMID: 30092266
Mikhaylov D, Ungar B, Renert-Yuval Y, Guttman-Yassky E. Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. 2023;130(5):577-592. DOI: 10.1016/j.anai.2023.01.031.
Simpson, E. L., Bieber, T., Guttman-Yassky, E., et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. New England Journal of Medicine. 2016 Dec 15;375(24): 2335-2348.DOI:10.1056/NEJMoa1610020. PMID: 27690741
Published
Issue
Section
License
Copyright (c) 2025 Eleni Paschou, Aimilios Lallas, Katerina Bakirtzi , Dimitra Kiritsi , Efstratios Vakirlis, Eleni Sotiriou

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

